Relay Therapeutics Inc.
RLAY·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$17.87
Today
+2.7%
YTD
+111.0%
About
Relay Therapeutics, Inc. is an American clinical stage biotechnology company focused on the development of therapies through their research into protein motion and protein function. The firm, founded in 2016, is based in Cambridge, Massachusetts, and trades on NASDAQ GM with the ticker RLAY. Add RLAY stock to your eToro watchlist today.
Price chart
Closing price history for RLAY (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-12.38
P/S (TTM)380.02
P/B (TTM)4.76
Market cap$4.25B
Cap tierMid-cap
Industry avg P/E-2.16
Profitability
Gross margin78.64%
EBIT margin-2999.37%
Net margin-23916.29%
ROE-36.77%
ROA-33.72%
Earnings & Revenue
Revenue (TTM)$10.35M
Revenue growth (1Y)+23.9%
EPS (TTM)-$1.57
Free cash flow$-212.21M
Total debt$30.66M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.86
Employees192
Next earnings5 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.